same peptide FAQ

Request certificates of analysis for both SKUs and compare the molecular weight, amino-acid sequence, and purity percentages. If the CoAs show identical specifications (1815.1 Da, Tyr-hGH 176-191, ≥98% purity), they're the same peptide sold under different product codes. Likely for inventory or regulatory filing reasons. If the specifications differ, one may be a lower-purity batch or an entirely different peptide mislabeled. This happens more often than it should in the peptide supply market.

Batch-to-batch variability in peptide synthesis can produce purity differences of 2–5% even under GMP conditions. More commonly, the issue is post-reconstitution handling: peptides stored above 8°C or exposed to repeated freeze-thaw cycles lose activity rapidly. Before concluding the peptide quality changed, verify storage temperature logs and reconstitution technique. If both are controlled and results still differ, request CoA comparison between the two batch numbers. Purity drift below 96% explains most inconsistent outcomes.

Do not purchase peptides without verified CoA documentation. The absence of third-party testing means no confirmation that the vial contains AOD-9604 at the claimed purity, or even that it contains peptide at all. Lyophilized powders are visually indistinguishable. Mannitol, lactose, and other excipients look identical to peptides. Reputable suppliers provide batch-specific HPLC chromatograms and mass spectrometry results as standard practice. If a supplier can't produce this documentation on request, that's not a quality vendor.

Treat them as referencing the same compound. A 2005 paper citing 'AOD-9604' and a 2018 supplier whitepaper referencing 'AOD9604' are discussing the identical peptide fragment. The naming inconsistency complicates literature searches. PubMed and Google Scholar will return different result sets depending on whether you include the hyphen. But doesn't indicate different molecules. When conducting systematic reviews, search both terms separately and de-duplicate results manually.

Request certificates of analysis for both SKUs and compare the amino acid sequence data. If the molecular weight, HPLC purity, and sequence match exactly. And they should. The supplier is selling the same peptide under two catalogue entries, likely for database or SEO purposes. This isn't fraudulent but it's administratively redundant. Choose whichever listing has the clearer documentation or better unit pricing. If the supplier claims they're functionally different, ask for the specific structural difference in writing. There isn't one.

Proceed without concern. The compounds are identical. The protocol author used the hyphenated format because that's how the original Metabolic Pharmaceuticals literature spelled it, but the peptide's activity doesn't depend on punctuation. Verify that the supplier's product matches the sequence (residues 177–191 hGH) and purity grade (≥95% minimum, ≥98% preferred). If those align, the absence of a hyphen in the product name is irrelevant to experimental outcomes.

Not all research peptides receive CAS numbers, so the absence alone isn't disqualifying. However, if competing suppliers do list a CAS number for what they call SS-LUP-332, contact the vendor without the CAS and ask why theirs differs. It's possible they're selling a proprietary analog under a similar name, or that they haven't registered the compound formally. Request the amino-acid sequence, molecular weight, and a recent CoA. If those parameters match the CAS-registered version from other suppliers, the peptides are equivalent despite the missing registry entry. If the sequence differs or the vendor refuses to provide it, assume you're looking at a different compound and source elsewhere.

Compare the Certificates of Analysis for both batches. Check that the molecular weight matches within 0.1 Da, the HPLC purity exceeds 97%, and the amino-acid sequence is identical across both documents. If all three align, the formatting difference is cosmetic. The peptide inside both vials is the same. Store them together and treat them as a single compound in your inventory system. If the CoAs show divergent molecular weights or purity levels, treat them as separate entities regardless of name similarity. Use the higher-purity batch for critical assays and reserve the lower-purity stock for preliminary work or bulk applications where 95% purity suffices.

Request the amino acid sequence and molecular weight. GHK-Cu has a molecular weight of approximately 340 Da and a sequence of Gly-His-Lys-Cu²⁺. If the supplier cannot provide sequencing data or a certificate confirming copper content by atomic absorption, the product is not research-grade. Generic 'copper peptide' labels occasionally refer to other complexes (like copper-binding domains from larger proteins) that lack the wound healing and matrix remodelling activity specific to GHK-Cu. Don't assume equivalence without data.

Request three verification documents: (1) mass spectrometry confirming molecular weight of 1075 ± 2 Da, (2) HPLC chromatogram showing purity percentage and deletion sequence content, and (3) amino acid analysis confirming the Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2 sequence. If all three match and purity is ≥95%, the peptide is functionally equivalent to branded Snap-8. The synthesis method (SPPS with Fmoc chemistry) is standard across suppliers. Quality differences emerge in coupling efficiency and purification rigor, both visible in the purity percentage and impurity profile on the HPLC trace.

You received the correct compound. The COA lists the INCI or chemical name rather than the trademark. Snap-8 is a brand name; certificates of analysis use standardized chemical nomenclature (acetyl octapeptide-3, acetyl glutamyl heptapeptide-1, or the full amino acid sequence). Verify the molecular weight matches ~1075 Da and the purity meets your specification (≥95% for research, ≥85% for cosmetic formulation). If the sequence is correct and purity is within range, the product is what you ordered regardless of naming discrepancies.

Use the peptide you sourced. The hyphen doesn't change the structure, function, or experimental outcome. Cross-check the molecular weight (9117.5 Da for IGF-1 LR3) and sequence on the supplier's COA against published references. If those match, the notation difference is irrelevant. Document the supplier and lot number in your methods section so results can be replicated regardless of how future suppliers format the name.

Confirm that all studies used the 83-amino-acid Long R3 variant, not native 70-amino-acid IGF-1. The easiest check is half-life: if the study reports sustained activity beyond 12 hours without re-dosing, it's almost certainly LR3. If activity drops off within 30–60 minutes, it's native IGF-1. Notation inconsistency across literature is common, but the peptide's biological behavior. Especially half-life and IGFBP independence. Will reveal which form was actually used.

Unlikely. Reconstituted GHK-Cu stored at 2–8°C begins losing copper chelation stability after 4–6 weeks, with measurable declines in fibroblast proliferation assays by week 8. If your solution is three months old, assume copper dissociation has reduced biological activity to subtherapeutic levels. The peptide backbone may still be intact (verifiable by HPLC), but without the 1:1 copper ratio, it won't activate TGF-β pathways or stimulate collagen synthesis at published rates. Discard and reconstitute fresh stock for reliable results.

Order from neither until you resolve the discrepancy. Request the full amino-acid sequence from both suppliers and compare them residue-by-residue. If the sequences differ, one supplier is mislabeling a different peptide under the SS-LUP-332 identifier. This happens when internal catalog systems assign codes without cross-checking existing nomenclature. If the sequences match but molecular weights diverge by more than 1 Da, one supplier is reporting incorrect data or synthesizing impure product. Ask for recent CoA documentation showing HPLC purity above 98% and mass spectrometry confirming the calculated molecular weight. Only proceed with the supplier whose spectrometric data matches the expected mass for the stated sequence.

Request the certificate of analysis (COA) and amino acid sequence for both listings. If the sequences are identical and both show 83 amino acids with the Long R3 modification, they're the same product listed twice under different notations. Some suppliers duplicate catalog entries to capture search traffic for both naming conventions. If the sequences differ. Or one is 70 amino acids instead of 83. One listing is native IGF-1, not the LR3 variant. Always verify peptide length and modification status before ordering.

Snap-8 carries published clinical data showing wrinkle depth reduction at 10% concentration in topical emulsions, which can support marketing claims if your formulation matches the tested concentration and delivery method. Generic acetyl octapeptide-3 at identical purity and concentration delivers the same biological activity, but you'll need independent efficacy testing to substantiate marketing claims unless you cite published third-party research on the peptide (not specific to the Snap-8 brand). The brand name doesn't change the peptide's function. It provides pre-existing documentation that reduces your clinical validation burden.

No. You received the same molecule under a different name. Verify the CAS number on your certificate of analysis reads 49557-75-7 and confirm HPLC purity is ≥98%. If both match, the peptide is identical regardless of whether the supplier labeled it AHK-Cu, GHK-Cu, or copper peptide GHK. The functional test: reconstitute a small aliquot and confirm it dissolves to a clear, slightly blue-tinted solution. The copper ion imparts a faint color that's absent in copper-free peptides.

A faint blue tint is normal. It indicates copper ion presence. Pure lyophilised GHK-Cu ranges from off-white to pale blue depending on copper content and residual moisture. However, a deep or dark blue color suggests excess free copper that isn't properly chelated to the peptide, which increases oxidative stress risk in cell culture models. Request a certificate of analysis confirming the copper-to-peptide ratio by ICP-MS before using the batch in any assay where metal ion toxicity could confound results.

Proceed with the 'LR3' product if the CAS number matches. Protocol replication depends on molecular structure, not naming convention. Include a note in your methods section citing both names and the CAS number to clarify for peer reviewers that no substitution occurred. Most institutional review boards and journal editors recognize the naming equivalence, but explicit documentation prevents delays during manuscript review.